Search E-Book
Deviation Handling in Pharmaceutical Manufacturing π | From Event to CAPA
A deviation is not simply a problem to be closed—it is an opportunity to identify weaknesses, understand root causes, strengthen processes, and prevent recurrence.
An effective deviation management system should focus on:
πΉ Early detection & timely reporting
πΉ Complete and accurate documentation
πΉ Impact & risk assessment
πΉ Root Cause Analysis (RCA)
πΉ Thorough investigation
πΉ Effective CAPA
πΉ CAPA effectiveness verification
πΉ QA review & closure
πΉ Trending and Continuous Improvement
π― The objective is not to find someone to blame. The objective is to find the true root cause and prevent recurrence.
Report → Investigate → Correct → Prevent → Verify → Improve
π Regulatory framework includes US FDA 21 CFR Part 211, EU GMP Annex 15, ICH Q10, WHO GMP and PIC/S GMP principles.
Every deviation is a learning opportunity. Every effective CAPA strengthens the Pharmaceutical Quality System.
π www.pharmatext.co.in
Your Compliance Partner in Pharma Excellence
PharmaText PharmaceuticalIndustry PharmaManufacturing Deviation DeviationManagement GMP cGMP CAPA RootCauseAnalysis RCA QualityAssurance QualityControl PharmaceuticalQuality ICHQ10 EUGMP USFDA PICS WHOGMP PharmaCompliance QualityManagement ContinuousImprovement PatientSafety DataIntegrity GMPCompliance PharmaProfessionals PharmaQuality PharmaceuticalSciences LifeSciences GoodManufacturingPractice QualityCulture
Subscribe to:
Post Comments (Atom)

No comments:
Post a Comment